acute myeloid leukemia


Also found in: Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.
Related to acute myeloid leukemia: Chronic Myeloid Leukemia
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.acute myeloid leukemia - acute leukemia characterized by proliferation of granular leukocytesacute myeloid leukemia - acute leukemia characterized by proliferation of granular leukocytes; most common in adolescents and young adults
acute leukemia - rapidly progressing leukemia
granulocytic leukemia, myelocytic leukemia - a malignant neoplasm of blood-forming tissues; marked by proliferation of myelocytes and their presence in the blood
References in periodicals archive ?
The study is based on an earlier completed open-label, non-randomised phase IIa clinical trial in acute myeloid leukemia where CX-01 was administered in combination with induction chemotherapy to 11 patients with newly diagnosed primary AML.
Demographic and Clinical Characteristics of Adult Acute Myeloid Leukemia - Tertiary Care Experience.
Acute myeloid leukemia (AML) is a heterogeneous disease with diverse genomic aberrations in the subtypes.
Additionally, the report provides an overview of key players involved in therapeutic development for Refractory Acute Myeloid Leukemia and features dormant and discontinued projects.
The Acute Myeloid Leukemia (AML) EpiCast Report provides an overview of the risk factors and global trends of AML in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan).
Documents of 173 patients diagnosed to have acute myeloid leukemia were evaluated in the study.
Acute myeloid leukemia with t(8; 21) and inv(16) are collectively referred to as core-binding factor (CBF) AML because RUNX1 (rearranged in t[8; 21]) and CBFB (rearranged in inv[16]) are both subunits of the CBF transcription complex, which is critical for myeloid differentiation.
Keywords: Acute Myeloid Leukemia NPM1 gene mutations Blast count.
This study can reassure patients who receive adjuvant chemotherapy to battle their cancer that their risk of a secondary acute myeloid leukemia and myelodysplastic syndrome is very low within the first three years.
The new work also suggests why a handful of older drugs developed to treat acute myeloid leukemia by targeting FTL3 have previously failed in clinical trials.
Acute myeloid leukemia (AML) is a disorder of differentiation and maturation of myeloid progenitors in the bone marrow.

Full browser ?